TRPs R6

General Information


DRACP ID  DRACP02835

Peptide Name   TRPs R6

Sequence  RWWKWW

Sequence Length  6

UniProt ID  P33432 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP Membrane lysis Binding intracellular targets



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma IC50>250 μg/mL MTT assay 24 h 1

Hemolytic Activity  Sheep erythrocytes: No hemolysis up tp 500 µg/ml

Normal (non-cancerous) Cytotoxicity  NIH 3T3: IC50=250 µg/ml

Target  Not available

Affinity  Not available

Mechanism  Dual mechanism, with the disruption of the membrane integrity possibly being the main cause of cell death, but only after peptide translocation and binding to intracellular targets.

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02835

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C56H66N14O7

Absent amino acids  ACDEFGHILMNPQSTVY

Common amino acids  W

Mass  113659

Pl  11.65

Basic residues  2

Acidic residues  0

Hydrophobic residues  4

Net charge  2

Boman Index  -1115

Hydrophobicity  -200

Aliphatic Index  0

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  22000

Absorbance 280nm  4400

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 33207639

Title  Effects of Rationally Designed Physico-Chemical Variants of the Peptide PuroA on Biocidal Activity towards Bacterial and Mammalian Cells

Doi 10.3390/ijms21228624

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPS_16986

DRACP is developed by Dr.Zheng's team.